HALO

HALOZYME THERAPEUTICS INC

Healthcare | Mid Cap

$1.24

EPS Forecast

$298.1

Revenue Forecast

Announcing earnings for the quarter ending 2025-06-30 soon
IOVAIovance Biotherapeutics IncREPLReplimune Group IncRVMDRevolution Medicines IncCRBUCaribou Biosciences IncDNLIDenali Therapeutics Inc